You Will Thank Us - 10 Tips About Xarelto Lawsuit You Need To Know

Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical companies, including the makers of Xarelto, possess a duty to make sure that their drugs are reasonably safe for use - and failure to do so may be grounds for compensation. Our lawyers are functioning challenging to have these hurt by the drug the compensation they are entitled to. While bleeding is really a typical complication related with anticoagulants, it has been alleged that Xarelto is more hazardous than conventional blood thinners since no antidote exists to reverse its blood-thinning effects. This indicates that, inside the event of an emergency, individuals could be at risk for irreversible bleeding troubles, such as life-threatening internal and gastrointestinal hemorrhaging. In case you or even a loved one suffered a serious bleeding occasion right after taking Xarelto, you might have legal recourse. For far more data, get in touch with us these days to have your case reviewed, free of charge. Compensation Possibilities xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for past and future health-related bills, lost wages, pain and suffering and, in instances of wrongful death for xarelto bleeding, funeral expenditures. Additionally, they are seeking punitive damages, which are usually awarded to punish the defendant and deter other organizations from acting similarly. Why Are Lawsuits Becoming Filed? Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding inside the event of an emergency. Plaintiffs within the lawsuits allege critical and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug. In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging: The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors. The makers of the drug continue to market Xarelto as a safe anticoagulant option. Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user in the event of a bleeding complication. Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion. Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting. Visit this page for far more details on the alleged health risks of Xarelto. Multidistrict Litigation Trial Dates Set The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.